These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 16414236

  • 1. An audit of surgical management of gastrointestinal stromal tumours (GIST).
    Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, Buhler LH, Morel P.
    Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
    [Abstract] [Full Text] [Related]

  • 2. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, Schleck CD, Hodge DO, Donohue JH.
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [Abstract] [Full Text] [Related]

  • 3. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY.
    Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358
    [Abstract] [Full Text] [Related]

  • 4. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.
    Cancer; 2008 Feb 01; 112(3):608-15. PubMed ID: 18076015
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
    Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, Bonvalot S.
    Eur J Surg Oncol; 2004 Dec 01; 30(10):1098-103. PubMed ID: 15522557
    [Abstract] [Full Text] [Related]

  • 6. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S, Pauser U, Egberts JH, Schafmayer C, Tepel J, Fändrich F.
    Eur J Surg Oncol; 2006 Dec 01; 32(10):1125-9. PubMed ID: 16859873
    [Abstract] [Full Text] [Related]

  • 7. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
    Chen CW, Wu CC, Hsiao CW, Fang FC, Lee TY, Che FC, Tsai WC, Jao SW.
    Z Gastroenterol; 2008 Aug 01; 46(8):760-5. PubMed ID: 18759198
    [Abstract] [Full Text] [Related]

  • 8. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 01; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 9. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
    An JY, Choi MG, Noh JH, Sohn TS, Kang WK, Park CK, Kim S.
    Eur J Surg Oncol; 2007 Oct 01; 33(8):1030-5. PubMed ID: 17428635
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P, Wozniak A, Dębiec-Rychter M, Kąkol M, Dziewirski W, Zdzienicki M, Ptaszynski K, Jurkowska M, Limon J, Siedlecki JA.
    Cancer; 2011 Nov 01; 117(21):4916-24. PubMed ID: 21456019
    [Abstract] [Full Text] [Related]

  • 11. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
    Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC.
    J Clin Oncol; 2008 Feb 01; 26(4):626-32. PubMed ID: 18235122
    [Abstract] [Full Text] [Related]

  • 12. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.
    Nunobe S, Sano T, Shimada K, Sakamoto Y, Kosuge T.
    Jpn J Clin Oncol; 2005 Jun 01; 35(6):338-41. PubMed ID: 15928191
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y, Cao H, Wang M, Shen DP, Shen ZY, Ni XZ, Wu ZY, Shen YY, Liu Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar 01; 12(2):150-4. PubMed ID: 19296250
    [Abstract] [Full Text] [Related]

  • 14. What is the prognostic significance of metastatic lymph nodes in GIST?
    Valadão M, de Mello EL, Lourenço L, Vilhena B, Romano S, Castro Ldos S.
    Hepatogastroenterology; 2008 Mar 01; 55(82-83):471-4. PubMed ID: 18613390
    [Abstract] [Full Text] [Related]

  • 15. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate?
    Goh BK, Chow PK, Kesavan S, Yap WM, Wong WK.
    J Surg Oncol; 2008 Apr 01; 97(5):388-91. PubMed ID: 18163461
    [Abstract] [Full Text] [Related]

  • 16. [Surgical treatment for primary gastrointestinal stromal tumors: a report of 73 cases].
    Zhang W, Shao QS, Ye ZY, Zhao ZS, Wang YD, Zhu YW.
    Zhonghua Wai Ke Za Zhi; 2009 Jan 15; 47(2):98-101. PubMed ID: 19563001
    [Abstract] [Full Text] [Related]

  • 17. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
    Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Kim HC, Kim KH, Yook JH, Kim BS, Kang YK.
    J Surg Oncol; 2008 Jul 01; 98(1):27-33. PubMed ID: 18452195
    [Abstract] [Full Text] [Related]

  • 18. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, Maurel J, Calabuig S, Gutierrez A, González de Sande JL, Martínez J, De Juan A, Laínez N, Losa F, Alija V, Escudero P, Casado A, García P, Blanco R, Buesa JM, Spanish Group for Sarcoma Research.
    J Clin Oncol; 2005 Sep 01; 23(25):6190-8. PubMed ID: 16135486
    [Abstract] [Full Text] [Related]

  • 19. [Gastrointestinal stromal tumour: our experience].
    Versaci A, Macrì A, Ieni A, Terranova M, Leonello G, Saladino E, Speciale G, Famulari C.
    Chir Ital; 2009 Sep 01; 61(2):161-9. PubMed ID: 19536989
    [Abstract] [Full Text] [Related]

  • 20. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P, Nowecki Z, Nyckowski P, Dziewirski W, Grzesiakowska U, Nasierowska-Guttmejer A, Krawczyk M, Ruka W.
    J Surg Oncol; 2006 Mar 15; 93(4):304-11. PubMed ID: 16496358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.